Searched for
GENERIC DRUG TEVA
DRL, Cipla, Aurobindo among others to buy products from TevaThe remedy requires Teva to divest the drug portfolio to 11 firms and marks the largest drug divestiture order in an FTC pharmaceutical mer...29 Jul, 2016, 03.41 PM IST- Teva’s hostile bid for Mylan: Deal could open up a $2-billion opportunity for pharma companiesAccording to experts, there is a possibility that the fruition of the deal will open up a $2-billion opportunity for Indian generic pharma ...23 Apr, 2015, 01.59 PM IST
- Teva offers to buy Mylan for $40.1 billionTeva, the world’s biggest maker of generic medicines, offered $82 a share in cash and stock for Mylan, according to a statement.22 Apr, 2015, 04.42 AM IST
- Teva may move court against Dr Reddy's for patent infringementThe Israeli drug maker already is involved in various legal battles with other drug firms over the patent litigations of Copaxone.11 Aug, 2014, 03.50 PM IST
- Teva settles patent dispute with Orchid PharmaTeva has settled patent dispute with Orchid Chemicals & Pharma pertaining to Parkinson’s disease drug Azilect (rasagiline mesylate) in the ...01 May, 2013, 10.45 PM IST
- Indian pharma companies like Aurobindo and Glenmark set to gain from USFDA nod for asthma drugIndian drug makers are set to benefit from a decision by the USFDA to allow sale of generic Singulair tablets used for treating asthma and ...05 Aug, 2012, 12.08 PM IST
- Ranbaxy Laboratories falls on payment concerns to Teva Pharmaceuticals, delay in settlment with FDARanbaxy's share price fell 1.66% due to concerns about payment to Teva Pharmaceuticals and delay in settlement with US authorities.03 Dec, 2011, 06.12 AM IST
- Teva to buy Taiyo stake for $460 million, bid for restTeva Pharmaceutical Industries Ltd agreed to buy 57% of Taiyo Pharmaceutical Industry Co Ltd. for $460 million and bid for the rest.17 May, 2011, 06.21 AM IST
- Dr Reddy's reach settlement with Wyeth over EffexorDr Reddy's Laboratories has reached a deal with Wyeth LLC over a patent litigation involving generic version of blockbuster anti-depressant...22 Apr, 2011, 09.18 PM IST
- Lupin can't sell pill in US, Teva files patent suitIsraeli drugmaker Teva Pharma has filed a patent infringement suit in the US against Lupin that prevents the Indian pharma company from sel...20 Jan, 2010, 03.45 AM IST
- Teva, Glenmark call an end to patent disputeIsraeli generic major Teva and Mumbai-based Glenmark Pharmaceuticals have settled a patent dispute over various generic versions of Coreg -...23 Apr, 2009, 01.14 AM IST
- Teva to buy Barr Pharma for $7.5 bnIn the latest drug consolidation, Teva Pharmaceutical said on Friday it will buy rival generic drugmaker Barr Pharmaceuticals for nearly $7...19 Jul, 2008, 01.17 AM IST
- Teva’s protonix version sale in US to hit SunIn a development which may impact Sun Pharma’s hopes of a windfall by selling generic versions of Wyeth’s $2.5-billion drug Protonix.26 Dec, 2007, 04.14 AM IST
- TEVA TO buy local unit for Rs 400 crThe world’s largest generic drug manufacturer Teva may be close to acquiring domestic company Saraca Labs’ manufacturing plant in Hyderabad...29 Jun, 2007, 01.39 AM IST
- DRL expects verdict in Aciphex case by May 15As the patent clash between Dr Reddy's Labs (DRL) and Japanese pharma firm Eisai for the control over $1.3-billion anti-ulcer drug Aciphex ...05 Apr, 2007, 02.27 AM IST
- US court rejects Novartis bid to sell Zocor genericsThe path was cleared for generic versions of Merck’s blockbuster Zocor cholesterol drug on Friday, after a US federal judge rejected a last...24 Jun, 2006, 03.47 AM IST
- Co may benefit from Zocor patent expiryWith barely two days left for patents on Merck’s ‘Zocor’ - the world’s No.2 cholestrol drug - to expire, the market seems to be betting tha...22 Jun, 2006, 12.35 AM IST
Load More
